Cabergoline
Cabergoline is a prescription medication available as 0.5 mg oral tablets, used to treat conditions like high prolactin levels or Parkinson's disease. It's a generic drug approved under ANDA076310 by Strides Pharma and marketed by various manufacturers. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| contactPoint |
{
"fn": "U.S. Food and Drug Administration (FDA)",
"@type": "vcard:Contact",
"hasEmail": "mailto:no-reply@healthdata.gov"
}
|
| description | Cabergoline is a prescription medication available as 0.5 mg oral tablets, used to treat conditions like high prolactin levels or Parkinson's disease. It's a generic drug approved under ANDA076310 by Strides Pharma and marketed by various manufacturers. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Cabergoline",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Cabergoline — ANDA 203308 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203308"
}
]
|
| identifier | https://healthdata.gov/api/views/fdfu-et76 |
| issued | 2025-11-24 |
| keyword |
[
"drug-manufacturers",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://healthdata.gov/d/fdfu-et76 |
| modified | 2025-11-27 |
| publisher |
{
"name": "healthdata.gov",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Cabergoline |
